Company Management

Step Pharma

Biotechnology Research Saint-genis-pouilly, Ardèche, Fr 14 employees

Employees: 14
Contacts: 2
Emails: 2
Phones: 1

step-ph.com LinkedIn Crunchbase

Step Pharma Overview

Headquarters: Saint-genis-pouilly, Ardèche, Fr
Website: step-ph.com
Industry: Biotechnology Research
Employees: 14
Founded: 2014
Funding: 41.3M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Wilmington

About Step Pharma

Step Pharma is the world leader in the discovery and development of inhibitors of CTPS1 (cytidine triphosphate synthase 1) for the treatment of cancer and autoimmune diseases. Step Pharma’s lead program dencatistat (STP938) is a first in class, potent, selective, oral inhibitor of CTPS1 with demonstrated anti-tumor activity. Dencatistat entered clinical development in 2022 in a PhI/II study for the treatment of relapsed and refractory T-cell and B-cell lymphoma. More recently a solid tumour study was started focused on ovarian cancer using the concept of synthetic lethality and biomarker selection of patients. This can ultimately be viewed as a tumour agnostic approach with ovarian cancer being the PoC indication and future plans to expand into other tumour types such as NSCLC with high prevalence of the biomarker.

Step Pharma Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Step Pharma Org Chart

Sample employees and titles

Name	Title	Location	Contact
Nicolas Marsault	CFO Step Pharma Sas	Geneva, Switzerland	View
Claus Andersson	Investing in Life Sciences - General	Copenhagen, Capital Region of Denmark, Denmark	Email Phone
Andy Parker	Chief Executive Officer at Step Pharma		View
Erik Van Den Berg	Executive, Chairman, Entrepreneur	The Randstad, Netherlands	Email